The sponsor identified 3 economic studies, all in UK settings. Taylor et al. (2009) carried out a cost-effectiveness analysis on non-union tibial fractures treated by EXOGEN or by surgery ...
August 4, 2006 — The US Food and Drug Administration (FDA) has approved a bone healing system that accelerates the time to healing in fresh, closed, posteriorly displaced distal radius fractures and ...
SAN FRANCISCO (MarketWatch) -- Smith & Nephew's Plc's orthopaedic trauma & clinical therapies division said Tuesday the Food and Drug Administration has approved its Exogen 4000+ bone healing system.
The new EXOGEN, which replaces the previous EXOGEN 4000+ model, is portable and more user friendly, with its new color LCD screen, splash-proof casing, and sleeker, lightweight design; and more ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results